# Bioequivalence and Food Effect Bioavailability Study of Lumacaftor Film-Coated Tablets

> **NCT05968612** · PHASE1 · COMPLETED · sponsor: **Qanatpharma Canada LTD** · enrollment: 39 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Lumacaftor 200 mg/Ivacaftor 125 mg Film-Coated Tablet
- **DRUG:** Lumacaftor 200 mg Film-Coated Tablet Formulation

## Key facts

- **NCT ID:** NCT05968612
- **Lead sponsor:** Qanatpharma Canada LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-17
- **Primary completion:** 2023-12-18
- **Final completion:** 2023-12-18
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2023-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05968612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05968612, "Bioequivalence and Food Effect Bioavailability Study of Lumacaftor Film-Coated Tablets". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT05968612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*